Literature DB >> 29252167

Pharmacological management of neuropsychiatric symptoms in patients with major neurocognitive disorders.

Dominique Elie1, Soham Rej1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29252167      PMCID： PMC5747538          DOI： 10.1503/jpn.170117

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN： 1180-4882            Impact factor:   6.186


× No keyword cloud information.
  26 in total

Review 1.  Antidepressant-Associated Hyponatremia in the Elderly.

Authors:  H Karl Greenblatt; David J Greenblatt
Journal:  J Clin Psychopharmacol       Date:  2016-12       Impact factor: 3.153

2.  The American Psychiatric Association Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia.

Authors:  Victor I Reus; Laura J Fochtmann; A Evan Eyler; Donald M Hilty; Marcela Horvitz-Lennon; Michael D Jibson; Oscar L Lopez; Jane Mahoney; Jagoda Pasic; Zaldy S Tan; Cheryl D Wills; Richard Rhoads; Joel Yager
Journal:  Am J Psychiatry       Date:  2016-05-01       Impact factor: 18.112

Review 3.  Antidepressant use in the elderly: the role of pharmacodynamics and pharmacokinetics in drug safety.

Authors:  Janet Sultana; Edoardo Spina; Gianluca Trifirò
Journal:  Expert Opin Drug Metab Toxicol       Date:  2015-03-03       Impact factor: 4.481

4.  Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials.

Authors:  Lon S Schneider; Karen S Dagerman; Philip Insel
Journal:  JAMA       Date:  2005-10-19       Impact factor: 56.272

Review 5.  Behavioural changes and psychological symptoms in dementia disorders.

Authors:  Ian McKeith; Jeffrey Cummings
Journal:  Lancet Neurol       Date:  2005-11       Impact factor: 44.182

Review 6.  Interventions for Neuropsychiatric Symptoms in Neurocognitive Impairment Due to Alzheimer's Disease: A Review of the Literature.

Authors:  Tamela D McClam; Christopher M Marano; Paul B Rosenberg; Constantine G Lyketsos
Journal:  Harv Rev Psychiatry       Date:  2015 Sep-Oct       Impact factor: 3.732

Review 7.  Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology.

Authors:  John T O'Brien; Clive Holmes; Matthew Jones; Roy Jones; Gill Livingston; Ian McKeith; Peter Mittler; Peter Passmore; Craig Ritchie; Louise Robinson; Elizabeth L Sampson; John-Paul Taylor; Alan Thomas; Alistair Burns
Journal:  J Psychopharmacol       Date:  2017-01-20       Impact factor: 4.153

Review 8.  Use of Benzodiazepines in Alzheimer's Disease: A Systematic Review of Literature.

Authors:  Michaela Defrancesco; Josef Marksteiner; W Wolfgang Fleischhacker; Imrich Blasko
Journal:  Int J Neuropsychopharmacol       Date:  2015-05-19       Impact factor: 5.176

9.  Recommendations of the 4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD4).

Authors:  Serge Gauthier; Christopher Patterson; Howard Chertkow; Michael Gordon; Nathan Herrmann; Kenneth Rockwood; Pedro Rosa-Neto; Jean-Paul Soucy
Journal:  Can Geriatr J       Date:  2012-12-04

Review 10.  Pharmacological treatments for neuropsychiatric symptoms of dementia in long-term care: a systematic review.

Authors:  Dallas P Seitz; Sudeep S Gill; Nathan Herrmann; Sarah Brisbin; Mark J Rapoport; Jenna Rines; Kimberley Wilson; Ken Le Clair; David K Conn
Journal:  Int Psychogeriatr       Date:  2012-10-19       Impact factor: 3.878
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.